2. Research agreement with APOVIA, Inc. for a
stable hepatitis B vaccine formulation (ICC-1132).
Total
Award: $10,000 9/1/02
–
3.
Pre-doctoral PhRMA
Fellowship Awarded to Michael Spelios
Total Award: $31,000 01/01/06-07/31/07
4. NIH EB004863-01A1 Principal Investigator priority score 157
Total
Award: $150,000 04/01/06-03/31/09